Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05030441 |
|
Recruitment Status :
Recruiting
First Posted : September 1, 2021
Last Update Posted : May 20, 2024
|
Sponsor:
Washington University School of Medicine
Collaborators:
Servier Hellas Pharmaceuticals Ltd.
Gateway for Cancer Research
Information provided by (Responsible Party):
Washington University School of Medicine
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 30, 2026 |
| Estimated Study Completion Date : | June 30, 2026 |